Gesffiset (Ethinylestradiol, Levonorgestrel | Lactose)

Gesffiset is a combined oral contraceptive containing Ethinylestradiol and Levonorgestrel. It is used for birth control and may also help regulate menstrual cycles. This medication is manufactured by Laboratorios Effik in the EU.

Gesffiset is primarily used as a contraceptive to prevent pregnancy. It works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg. Some individuals may also use it to manage menstrual irregularities or reduce symptoms of premenstrual syndrome (PMS).

Common effects of Gesffiset may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users might experience mild side effects like nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Gesffiset should be used as directed by a healthcare provider. It is important to inform your healthcare provider about any pre-existing conditions, such as blood clots, liver disease, or a history of breast cancer. Regular check-ups are recommended to monitor for any potential side effects.

Gesffiset may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. It is advisable to consult a healthcare provider before starting or stopping any new medications while using Gesffiset. Additionally, smoking and excessive alcohol consumption may affect the efficacy of the medication.